Engineering Success
Overview
As part of our project Scentinel, we aim to produce seven valuable terpenes: limonene, ocimene, cineole, borneol, myrcene, nerolidol, and nerol. To achieve this goal, we successfully constructed 19 plasmids and transformed them into Saccharomyces cerevisiae chassis strain. This strategic approach enabled us to engineer yeast for terpene biosynthesis. Ultimately, we achieved the successful production of four terpenoids: ocimene, cineole, nerolidol, and nerol. Additionally, we explored the conditional release of these aromatic compounds in yeast.
Figure 1: Engineered pathway for the production of terpenes in Saccharomyces cerevisiae
Figure 2: Summary of experimental results
Synthetic biology applies engineering design principles to modify or recreate organisms for specific functions, typically following an iterative Design-Build-Test-Learn (DBTL) cycle. In accordance with this methodology, we undertook three cycles of genetic editing on Saccharomyces cerevisiae aimed at achieving heterologous expression and conditional release of various terpenoids.
In the initial phase of our study, we investigated the mevalonate (MVA) pathway in Saccharomyces cerevisiae for the production of terpene products, thereby confirming the viability of this metabolic route for biotechnological applications. During this phase, we also identified the critical influence of promoter and terminator selection on fermentation yield, which underscored the importance of regulatory elements in optimizing metabolic processes. This foundational work established a robust basis for further research. In the subsequent phase, we directed our efforts towards synthesizing a variety of functional terpenoid compounds to address product demands, with the objective of enhancing both the yield and diversity of these compounds for industrial use. Finally, in the third phase, we explored conditional expression strategies by employing the GAL1 promoter to tightly regulate the production of target terpenes. Through this iterative process, we aimed to refine our engineering strategies, ultimately leading to a more efficient and controlled biosynthesis of terpenoids in S. cerevisiae.
Figure 3: Experimental operation procedure
Figure 4: Engineering cycle diagram of our project (D=Design, B=Build, T=Test, L=Learn)
Engineering Cycle 1: Validating Our System
Proof of Concept with Ocimene
Design
Our goal is to successfully produce terpenes in yeast and to verify the pathway feasibility. Due to the fast growth rate of E.coli and the ease of molecular cloning, we decide to construct and verify plasmids in E.coli. The gene CcOCS encoding ocimene synthase from C.camphora were synthesized by Gene Synthesis Platform according to the codon bias of S. cerevisiae and ligated into the plasmid, we then assembled it into vector HcKan-O by golden gate cloning, and then constructed with promoters (pTHD3, pGPM1, pINO1) and terminators (ADH1t, PGK1t, TEF1t) into shuttle plasmid vector. Heterologous expression of CcOCS with different promoters and terminators in S. cerevisiae.
Snapgene diagrams of ocimene synthase gene: CcOCS.
HcKan-O Vector
HcKan-O-CcOCS
pINO1
pGPM1
pTDH3
ADH1t
PGK1t
TEF1t
POT2_pINO1 CcOCS_TEF1t
POT2_pTDH3_CcOCS_ADH1t
POT vector
POT2_pGPM1_CcOCS_PGK1t
Build
We have completed the construction and validation of the final plasmid through three main processes.
- Plasmid Extraction.
- The TPS gene was cloned into the HcKan-O vector. (Colony PCR, Enzymatic Digestion, Gene sequencing)
- Assembled the TPS gene with different promoters and terminators into shuttle vectors. (Colony PCR, Enzymatic Digestion, gene sequencing)
Figure 5: Colony PCR results performed to screen strain HcKan-O-CcOCS
Figure 6: Colony PCR results performed to screen strain. A: POT2_pGPM1_CcOCS_PGK1t, B: POT2_pINO1_CcOCS_TEF1t, C: POT2_pTDH3_CcOCS_ADH1t
Figure 7: Single colonies of plasmid transformants on LB Ampicillin plate
Strain 2 and 16 have been confirmed positive by sequencing
Strain 4 and 7 have been confirmed positive by sequencing
Strain 6 and 8 have been confirmed positive by sequencing
Strain 1 and 5 have been confirmed positive by sequencing
Test
The colony PCR Gel Electrophoresis Results of CcOCS
We introduced the constructed plasmids into Saccharomyces cerevisiae through transformation and verify successful transformation by yeast colony PCR. The results showed that we successfully transformed plasmids POT2_pINO1_CcOCS_TEF1t and POT2_pTDH3_CcOCS_ADH1t into the yeast, while the verification for the POT2_pGPM1_CcOCS_PGK1t plasmid failed.
Figure 8: Yeast colony PCR result performed to screen strain A: BY4741-POT2_pGPM1_CcOCS_PGK1t, B: BY4741-POT2_pINO1_CcOCS_TEF1t, C: BY4741-POT2_pTDH3_CcOCS_ADH1t(M=DL5000 marker;P=Positive; N=Negative)
Figure 9: Yeast single colonies of plasmid transformants on SC-URA plate
GC-MS analysis of ocimene :
To evaluate ocimene production in S. cerevisiae cells, shake flask fermentation was performed. After 12 hours of fermentation, a dodecane overlay culture was added, and the fermentation continued for a total of 120 hours. The ocimene titer reached 0.83 ± 0.06 mg/L when using the pINO1 promoter and TEF1t terminator, whereas it was 0.33 ± 0.09 mg/L with the pTDH3 promoter and ADH1t terminator.
Figure 10: Heterologous expression of CcOCS in S. cerevisiae. A: GC-MS analyses of ocimene extracts of S. cerevisiae expressing CcOCS with pTDH3 promoter and ADH1t terminator. B: GC-MS analyses of ocimene extracts of S. cerevisiae expressing CcOCS with the pINO1 promoter and TEF1t terminator. C: the OD600 and ocimene yield by CcOCS under the control of different promoters and terminators. The data represent the mean ± standard deviation of three independent experiments.
Learn
The successful production of ocimene demonstrates the feasibility of the MVA pathway in Saccharomyces cerevisiae. The production of ocimene varied significantly under the control of different promoters and terminators, despite no notable differences in OD600 values. In our human practice activities, we focused on synthesizing various terpenes to assist visually impaired women by alerting them to the onset of menstruation and potential leakage. Based on our literature research findings, we planed to utilize synthetic biology to produce a diverse range of terpenes.
Engineering Cycle 2: Expanding Our Terpene Library
Construction for producing Cineole, Nerol, Nerolidol etc.
Design
Based on product characteristics and literature research, we synthesized terpene synthase genes for three compounds: cineole, nerolidol, and nerolidol. The genes AcNES1 (nerolidol synthase from Actinidia chinensis), PgfB (nerol synthase from Penicillium griseofulvum), and HpyCins, StrCins, and SfCins (cineol synthases from Hypoxylon, Streptomyces clavuligerus, and Salvia fruticosa) were synthesized by Gene Synthesis Platform to match the codon bias of S. cerevisiae and then ligated into the plasmid.
Building on the first cycle, we constructed shuttle plasmids with various combinations of promoters and terminators using Golden Gate assembly. After transformed Saccharomyces cerevisiae and performed yeast colony PCR, we typically employed two-phase fermentation system for terpenoid production. We then test terpenoid production using gas chromatography–mass spectrometry.
Snapgene diagrams of three Cineole synthase genes: HpyCins, StrCins, SfCins.
HcKan-O-HpyCins
HcKan-O-StrCins
HcKan-O-SfCins
POT2_pGPM1 StrCins_PGK1t
POT2_pTDH3 HpyCins_ADH1t
POT2_pINO1 HpyCins_TEF1t
Snapgene diagrams of nerol synthase gene: PgfB.
HcKan-O-PgfB
POT2_pGPM1_PgfB_PGK1t
POT2_pTDH3_PgfB_ADH1t
POT2_pINO1_PgfB_TEF1
Snapgene diagrams of nerolidol synthase gene: AcNES1.
HcKan-O-AcNES1
POT2_pGPM1_AcNES1_PGK1t
POT2_pTDH3_AcNES1_ADH1t
POT2_pINO1_AcNES1_TEF1t
Build
New primers were ordered, and then we have completed the construction and validation of the final plasmid through the same method as cycle 1. We have successfully constructed 9 shuttle plasmids, which are
POT2_pTDH3_HpyCins_ADH1t, POT2_pINO1_HpyCins_TEF1t, POT2_pGPM1_StrCins_PGK1t,
POT2_pINO1_PgfB_TEF1t, POT2_pGPM1_PgfB_PGK1t, POT2_pTDH3_PgfB_ADH1t,
POT2_pINO1_AcNES1_TEF1t, POT2_pGPM1_AcNES1_PGK1t, POT2_pTDH3_AcNES1_ADH1t.
The colony PCR Gel Electrophoresis Results of HpyCins, StrCins and SfCins:
Figure 11: DH5α E.coli colony PCR results of HpyCins, StrCins and SfCins A: HcKan-O-SfCins B: HcKan-O-StrCins C: HcKan-O-HpyCins(M=DL5000 marker)
Figure 12: DH5α E.coli colony PCR results of HpyCins, StrCins and SfCins A: POT2_pTDH3_HpyCins_ADH1t (M=DL5000 marker) B: POT2_pINO1_HpyCins_TEF1t (M=DL5000 marker) C: POT2_pGPM1_StrCins_PGK1t(M=DL2000 marker)
Figure 13: Enzymatic digestion result of StrCins
The sequencing result:
Strain 10 and 13 have been confirmed positive by sequencing
Strain 2 and 3 have been confirmed incorrect by sequencing
Strain 6 and 8 have been confirmed positive by sequencing
Strain 3 and 4 have been confirmed positive by sequencing
Strain 3 and 10 have been confirmed positive by sequencing
Strain 1 and 3 have been confirmed positive by sequencing
The colony PCR Gel Electrophoresis Results of PgfB
Figure 14: DH5α E.coli colony PCR results of PgfB A: HcKan-O-PgfB, B: POT2_pINO1_PgfB_TEF1t, C: POT2_pGPM1_PgfB_PGK1t, D: POT2_pTDH3_PgfB_ADH1t(M=DL5000 marker)
Figure 15: Enzymatic digestion result of PgfB
The sequencing result:
Strain 2 and 3 have been confirmed positive by sequencing
Strain 8 and 9 have been confirmed positive by sequencing
Strain 1 and 2 have been confirmed positive by sequencing
Strain 1 and 2 have been confirmed positive by sequencing
The colony PCR Gel Electrophoresis Results of AcNES1
Figure 16: DH5α E.coli colony PCR results of AcNES1 A: HcKan-O-AcNES1. B: POT2_pINO1_AcNES1_TEF1t, POT2_pGPM1_AcNES1_PGK1t, POT2_pTDH3_AcNES1_ADH1t. C: Enzymatic digestion result of AcNES1. (M=DL5000 marker)
The sequencing result:
Strain 4 and 8 have been confirmed positive by sequencing
Strain 3 and 10 have been confirmed positive by sequencing
Strain 2 and 4 have been confirmed positive by sequencing
Strain 1 has been confirmed positive by sequencing
Figure 17: Single colonies of plasmid transformants on LB agar plates containing ampicillin or kanamycin
Test
The yeast colony PCR Gel Electrophoresis Results of HpyCins, PgfB and AcNES1:
Yeast colony PCR results confirmed that seven plasmids—POT2_pTDH3_HpyCins_ADH1t,
POT2_pINO1_HpyCins_TEF1t, POT2_pINO1_PgfB_TEF1t, POT2_pGPM1_PgfB_PGK1t,
POT2_pTDH3_PgfB_ADH1t, POT2_pGPM1_AcNES1_PGK1t, and POT2_pTDH3_AcNES1_ADH1t—were positive in Saccharomyces cerevisiae.
Figure 18: Yeast colony PCR result of cineole performed to screen strain.(M=DL5000 marker;P=Positive; N=Negative) HcKan-O-HpyCins(M=DL5000 marker)
Figure 19: Yeast colony PCR result of nerol performed to screen strain. A: BY4741-POT2_pGPM1_PgfB_PGK1t. B: BY4741-POT2_pINO1_PgfB_TEF1t. C: BY4741-POT2_pTDH3_PgfB_ADH1t.(M=DL5000 marker;P=Positive; N=Negative)
Figure 20: Yeast colony PCR result of nerolidol performed to screen strain. A: BY4741-POT2_pGPM1_AcNES1_PGK1t. B: BY4741-POT2_pTDH3_AcNES1_ADH1t. C: BY4741-POT2_pINO1_AcNES1_TEF1t.(M=DL5000 marker;P=Positive; N=Negative)
Figure 21: Yeast single colonies of plasmid transformants on SC-URA plate
GC-MS analysis of cineole:
Flask fermentation of HpyCins yielded 11.88 ± 2.03 mg/l of ocimene with the pINO1 promoter and TEF1t terminator, compared to 17.58 ± 3.20 mg/l with the pTDH3 promoter and ADH1t terminator.
Figure 22: Heterologous expression of HpyCins in S. cerevisiae. A: GC-MS analyses of cineole extracts of S. cerevisiae expressing HpyCins with pTDH3 promoter and ADH1t terminator. B: GC-MS analyses of cineole extracts of S. cerevisiae expressing HpyCins with the pINO1 promoter and TEF1t terminator. C: the OD600 and cineole yield by HpyCins under the control of different promoters and terminators. The data represent the mean ± standard deviation of three independent experiments.
GC-MS analysis of nerol:
Flask fermentation of PgfB yielded 6.07 ± 0.23 mg/l of nerol with the pTDH3 promoter and ADH1t terminator, but no terpenes are produced with pINO1 and GPM1 promoter.
Figure 23: Heterologous expression of PgfB in S. cerevisiae. A: GC-MS analyses of nerol extracts of S. cerevisiae expressing PgfB with pTDH3 promoter and ADH1t terminator. B: GC-MS analyses of nerol extracts of S. cerevisiae expressing PgfB with the pINO1 promoter and TEF1t terminator. C: GC-MS analyses of nerol extracts of S. cerevisiae expressing PgfB with the pGPM1 promoter and PGK1t terminator. D: The OD600 and nerol yield by PgfB under the control of different promoters and terminators. The data represent the mean ± standard deviation of three independent experiments.
GC-MS analysis of nerolidol:
Flask fermentation of AcNES1 yielded 45.06 ± 1.68 mg/l of nerolidol with the pTDH3 promoter and ADH1t terminator, compared to 12.92 ± 1.37 mg/l with the pGPM1 promoter and TEF1t terminator.
Figure 24: Heterologous expression of AcNES1 in S. cerevisiae. A: GC-MS analyses of nerolidol extracts of S. cerevisiae expressing AcNES1 with pTDH3 promoter and ADH1t terminator. B: GC-MS analyses of nerolidol extracts of S. cerevisiae expressing AcNES1 with the pGPM1 promoter and PGK1t terminator. C: The OD600 and nerolidol yield by AcNES1 under the control of different promoters and terminators. The data represent the mean ± standard deviation of three independent experiments.
Learn
The production of cineole varied significantly between different promoters and terminators. Flask fermentation using the pINO1 promoter and TEF1t terminator yielded 11.88 ± 2.03 mg/l of ocimene, while the pTDH3 promoter and ADH1t terminator produced 17.58 ± 3.20 mg/l, despite both constructs having similar OD600 values around 4.4. Similarly, flask fermentation with the pTDH3 promoter and ADH1t terminator resulted in 45.06 ± 1.68 mg/l of nerolidol, compared to 12.92 ± 1.37 mg/l with the pGPM1 promoter and TEF1t terminator, even though OD600 values for both constructs were similar at approximately 5. The results highlight the importance of the promoter in heterologous expression.
Although we are able to produce the scent molecules, we have not yet fully achieved the primary goal of our project: to provide reminders through the conditional release of sanitary napkins or laundry detergent and to make our product accessible to visually impaired women. Part of this limitation arises from safety restrictions imposed by the competition, but more significantly, we currently lack a viable implementation method. Our research confirms that scented sanitary napkin products are available on the market; however, there are no studies on the conditional release of fragrance in sanitary napkin products. Therefore, we have decided to focus on the conditional release of terpenes to explore the feasibility of this approach.
Engineering Cycle 3: Conditional Release test
Regulated synthesis of aromatic compounds by inducible promoters
Design
From our previous two experimental cycles, we have successfully engineered yeast to produce scents. Our next main focus will be to build a conditional release test for terpenes aimed at assisting visually impaired women. To achieve this, we will explore the use of regulatory promoters for the conditional release of terpenoids through synthetic biology. We have preliminarily selected two genes for investigation: AcNES1 (nerolidol synthase from Actinidia chinensis) and PgfB (nerol synthase from Penicillium griseofulvum). We will examine strategies for achieving conditional release from a synthetic biology perspective. The pGAL1 promoter is known for its strength in driving high levels of enzyme expression, which facilitates efficient production of the desired product. Therefore, we plan to utilize the pGAL1 promoter for plasmid construction, enabling the conditional release of terpenes from Saccharomyces cerevisiae.
Snapgene diagrams of three Cineole synthase genes: PgfB and AcNES1.
POT2_pGAL1_PgfB_PGK1t
POT2_pGAL1_AcNES1_PGK1t
Build
We have completed the construction and validation of the final plasmid through the same method as cycle 1.
We have successfully constructed two shuttle plasmids, which were POT2_pGAL1_PgfB_PGK1t, POT2_pGAL1_AcNES1_PGK1t.
The colony PCR Gel Electrophoresis Results of PgfB and AcNES1:
Figure 25: DH5α E.coli colony PCR results of PgfB and AcNES1 A: POT2_pGAL1_PgfB_PGK1t. B: POT2_pGAL1_AcNES1_PGK1t. C: Enzymatic digestion result of PgfB and AcNES1. (M=DL5000 marker)
Figure 26: Single colonies of plasmid transformants on LB ampicillin plate
The sequencing result:
Strain 2 and 6 have been confirmed positive by sequencing
Strain 1 and 2 have been confirmed positive by sequencing
Test
The colony PCR gel electrophoresis Results of PgfB and AcNES1:
Yeast colony PCR results confirmed that two plasmids—BY4741-POT2_pGAL1_AcNES1_PGK1t and BY4741-POT2_pGAL1_PgfB_PGK1t—were positive in Saccharomyces cerevisiae. We then selected single colonies for fermentation. In contrast to the previous two cycles, we employed a galactose-inducible promoter and chose SC-URA medium with both glucose and galactose as carbon sources for the control fermentation culture.
Figure 27: Yeast colony PCR results of nerolidol and nerol performed to screen strain. A: BY4741-POT2_pGAL1_AcNES1_PGK1t. B: BY4741-POT2_pGAL1_PgfB_PGK1t. (M=DL5000 marker;P=Positive; N=Negative)
Figure 28: Yeast single colonies of plasmid transformants on SC-URA plate
GC-MS analysis of nerol and nerolidol:
Flask fermentation of AcNES1 with the pGAL1 promoter and PGK1t terminator yielded 4.78 ± 0.88 mg/l of nerolidol, while no nerol production was detected.
Figure 29: Heterologous expression of AcNES1 in S. cerevisiae A: GC results of AcNES1 with glucose under the control of the pGAL1 promoter and PGK1t terminator. B: GC results of AcNES1 with galactose under the control of the pGAL1 promoter and PGK1t terminator.
Figure 30: Heterologous expression of PgfB in S. cerevisiae. A: GC results of PgfB with glucose under the control of the pGAL1 promoter and PGK1t terminator. B: GC results of PgfB with galactose under the control of the pGAL1 promoter and PGK1t terminator.
Figure 31: The OD600 and terpenes production by AcNES1 and PgfB under the control of pGAL1 promoter and PGK1t terminator
Learn
In detecting nerol from the PgfB gene with various combinations, only the pTDH3 and ADH1t combination yielded 6.07 ± 0.23 mg/l, while no terpenes were produced with the other combinations. GC-MS analysis revealed that the impurity peak around 8.2 minutes was identified as a solvent peak (dodecane), whereas the retention time for nerol was 8.4 minutes. Thus, the fermentation results from the three plasmids are likely influenced by the solvent peak. Future experiments will consider using n-hexane or ethyl acetate as extraction agents for re-evaluation.
In our comparison of nerolidol yields from the AcNES1 gene using various promoter and terminator combinations, we observed that galactose induction increased the yield 12-fold compared to glucose. However, this yield remained lower than the yield achieved by the constitutive promoter (45.1 mg/l). These results indicate that our approach to conditional release has shown initial success.
Reference
Ignea, C.; Cvetkovic, I.; Loupassaki, S.; Kefalas, P.; Johnson, C. B.; Kampranis, S. C.; Makris, A. M. Improving Yeast Strains Using Recyclable Integration Cassettes, for the Production of Plant Terpenoids. Microb. Cell Factories 2011, 10 (1), 4. https://doi.org/10.1186/1475-2859-10-4.
Shaw, J. J.; Berbasova, T.; Sasaki, T.; Jefferson-George, K.; Spakowicz, D. J.; Dunican, B. F.; Portero, C. E.; Narváez-Trujillo, A.; Strobel, S. A. Identification of a Fungal 1,8-Cineole Synthase from Hypoxylon Sp. with Specificity Determinants in Common with the Plant Synthases. J. Biol. Chem. 2015, 290 (13), 8511–8526. https://doi.org/10.1074/jbc.M114.636159.
Sun, J.; Wang, X.; Yu, K.; Zang, Y.; Qu, Z.; Wei, C.; Yuan, W. Expression of the Human Antiapoptotic Protein Bcl-2 Increases Nerolidol Production in Engineered Yeast. Process Biochem. 2022, 119, 90–95. https://doi.org/10.1016/j.procbio.2022.05.009.
Ma, R.; Su, P.; Guo, J.; Jin, B.; Ma, Q.; Haiyan, Z.; Chen, L.; Mao, L.; Tian, M.; Lai, C.; Tang, J.; Cui, G.; Huang, L. Bornyl Diphosphate Synthase From Cinnamomum Burmanni and Its Application for (+)-Borneol Biosynthesis in Yeast. Front. Bioeng. Biotechnol. 2021, 9, 631863. https://doi.org/10.3389/fbioe.2021.631863.
Cheng, S.; Liu, X.; Jiang, G.; Wu, J.; Zhang, J.; Lei, D.; Yuan, Y.-J.; Qiao, J.; Zhao, G.-R. Orthogonal Engineering of Biosynthetic Pathway for Efficient Production of Limonene in Saccharomyces Cerevisiae. ACS Synth. Biol. 2019, 8 (5), 968–975. https://doi.org/10.1021/acssynbio.9b00135
Zeng, W.; Jiang, Y.; Shan, X.; Zhou, J. Engineering Saccharomyces Cerevisiae for Synthesis of β-Myrcene and (E)-β-Ocimene. 3 Biotech 2023, 13 (12), 384. https://doi.org/10.1007/s13205-023-03818-2.
Guo, Y.; Dong, J.; Zhou, T.; Auxillos, J.; Li, T.; Zhang, W.; Wang, L.; Shen, Y.; Luo, Y.; Zheng, Y.; Lin, J.; Chen, G.-Q.; Wu, Q.; Cai, Y.; Dai, J. YeastFab: The Design and Construction of Standard Biological Parts for Metabolic Engineering in Saccharomyces Cerevisiae. Nucleic Acids Res. 2015, 43 (13), e88–e88. https://doi.org/10.1093/nar/gkv464.
Tang, H.; Wu, Y.; Deng, J.; Chen, N.; Zheng, Z.; Wei, Y.; Luo, X.; Keasling, J. D. Promoter Architecture and Promoter Engineering in Saccharomyces Cerevisiae. Metabolites 2020, 10 (8), 320. https://doi.org/10.3390/metabo10080320.
Tetali, S. D. Terpenes and Isoprenoids: A Wealth of Compounds for Global Use. Planta 2019, 249 (1), 1–8. https://doi.org/10.1007/s00425-018-3056-x.
McGinty, D.; Letizia, C. S.; Api, A. M. Addendum to Fragrance Material Review on Nerolidol (Isomer Unspecified). FOOD Chem. Toxicol. 2010, 48, S43–S45. https://doi.org/10.1016/j.fct.2009.11.008.
Mo, X.; Cai, X.; Hui, Q.; Sun, H.; Yu, R.; Bu, R.; Yan, B.; Ou, Q.; Li, Q.; He, S.; Jiang, C. Whole Genome Sequencing and Metabolomics Analyses Reveal the Biosynthesis of Nerol in a Multi-Stress-Tolerant Meyerozyma Guilliermondii GXDK6. Microb. CELL FACTORIES 2021, 20 (1), 4. https://doi.org/10.1186/s12934-020-01490-2.